Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2002 1
2003 3
2004 4
2005 1
2006 2
2007 7
2008 3
2009 3
2010 10
2011 23
2012 16
2013 10
2014 6
2015 6
2016 5
2017 5
2018 6
2019 4
2020 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21700528

106 results

Results by year

Filters applied: . Clear all
Page 1
Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors.
Van den Wyngaert T, Delforge M, Doyen C, Duck L, Wouters K, Delabaye I, Wouters C, Wildiers H. Van den Wyngaert T, et al. Support Care Cancer. 2013 Dec;21(12):3483-90. doi: 10.1007/s00520-013-1934-0. Epub 2013 Aug 18. Support Care Cancer. 2013. PMID: 23955094 Clinical Trial.
Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
Tanaka R, Yonemori K, Hirakawa A, Kinoshita F, Takahashi N, Hashimoto J, Kodaira M, Yamamoto H, Yunokawa M, Shimizu C, Fujimoto M, Fujiwara Y, Tamura K. Tanaka R, et al. Oncologist. 2016 Apr;21(4):508-13. doi: 10.1634/theoncologist.2015-0377. Epub 2016 Mar 14. Oncologist. 2016. PMID: 26975863 Free PMC article.
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial.
Llombart A, Frassoldati A, Paija O, Sleeboom HP, Jerusalem G, Mebis J, Deleu I, Miller J, Schenk N, Neven P. Llombart A, et al. Clin Breast Cancer. 2012 Feb;12(1):40-8. doi: 10.1016/j.clbc.2011.08.002. Epub 2011 Oct 19. Clin Breast Cancer. 2012. PMID: 22014381 Clinical Trial.
Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.
Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein MA, Coleman RE, Reitsma DJ, Chen BL, Seaman JJ. Rosen LS, et al. Cancer. 2003 Oct 15;98(8):1735-44. doi: 10.1002/cncr.11701. Cancer. 2003. PMID: 14534891 Free article. Clinical Trial.
106 results